Dylan Supina
About Dylan Supina
Dylan Supina serves as the Senior Director of Real World Evidence Analytics & Strategy at Geron Corporation, where he has worked since 2023. With extensive experience in health economics and market access, he has held various leadership roles across several pharmaceutical companies.
Work at Geron
Dylan Supina currently holds the position of Senior Director, Real World Evidence Analytics & Strategy at Geron Corporation. He has been with the company since 2023 and operates in a remote capacity from the Greater Philadelphia area. In this role, he focuses on leveraging real-world evidence to inform strategic decisions and enhance market access for the company's products.
Previous Experience in Pharmaceutical Industry
Prior to joining Geron, Dylan Supina accumulated extensive experience in the pharmaceutical industry. He served as Director, Global Evidence and Market Access at CSL Behring from 2018 to 2020. His career also includes roles such as Associate Director, Worldwide Market Access at Johnson & Johnson from 2006 to 2011, and Director, Health Economics and Outcomes Research at Jazz Pharmaceuticals from 2020 to 2022. Additionally, he worked as Principal at Main Line Analysis LLC from 2015 to 2018 and held a position as Associate Director at Wyeth Pharmaceuticals from 2004 to 2005.
Education and Expertise
Dylan Supina earned a Doctor of Philosophy (Ph.D.) in Economics from Penn State University. He also holds a Bachelor’s Degree in Economics from Virginia Tech. His educational background supports his specialization in converting data into evidence of value, which is essential for effective communication with stakeholders in the pharmaceutical sector.
Consulting Services and Value Propositions
Through Main Line Analysis, LLC, Dylan Supina provides consulting services focused on developing supportable Value Propositions and evidence generation plans. His expertise lies in aligning commercial and R&D teams to optimize market access strategies and enhance the value proposition of life science products.
Health Economics and Market Access Strategy
Dylan Supina combines his research and development experience in Health Economics and Outcomes Research with commercial expertise in Market Access. This unique blend allows him to effectively support life science product value propositions, ensuring that both internal and external stakeholders understand the evidence of value behind pharmaceutical products.